AXGN
Axogen, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$49.37
−0.52%Forward multiples
Based on analyst estimates
- P/E forward
- 74.20x
- P/E 2026E
- 88.37x
- P/E 2027E
- 69.01x
- P/E 2028E
- 50.37x
- P/S forward
- 8.44x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.94x
- Price / sales
- 11.05x
- Price / cash flow
- 130.29x
Enterprise value
- Enterprise value
- $2.6B
- EV / sales
- 9.82x
- EV / EBITDA
- -123.37x
- EV / EBIT
- -189.81x
- Market cap
- $2.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026